Skip to main content

InspireMD, Inc.

NSPR
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001433607

No open-market purchases or sales by InspireMD, Inc. insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $15.1M in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding InspireMD, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of NSPR: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders1523+8
Shares90.0K8.05M+7.96M (+8,851.3%)
Value$100.6K$20.2M+$20.1M (+19,992.6%)

New holders (11)

Institutions that held InspireMD, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to NSPR in Q2 2023
InstitutionSharesValue% of portfolio
OrbiMed Advisors LLC1,860,405$4.67M0.09%
Marshall Wace, LLP1,860,405$4.67M0.01%
Nantahala Capital Management, LLC1,860,405$4.67M0.57%
Soleus Capital Management, L.P.1,378,128$3.46M0.38%
Velan Capital Investment Management LP904,029$2.27M2.13%
Pura Vida Investments, LLC55,680$139.8K0.06%
Nottingham Advisors, Inc.25,000$62.8K0.01%
Renaissance Technologies LLC14,200$36.0K0.00%
Morgan Stanley10,000$25.1K0.00%
AdvisorNet Financial, Inc8,783$22.0K0.00%
Global Retirement Partners, LLC27$680.00%

Sold out (3)

Institutions that held InspireMD, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of NSPR in Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
Millennium Management LLC12,251$14.0K
Bank of America Corp1$1
Simplex Trading, LLC56$0